The aims of this study are to reveal the underlying inhibitory mechanism of a compound against the chemokine signal, based on targeted protein structures, and to evaluate the analgesic effect on allodynia-specific responses in a rat chronic pain model, with our BOLD-fMRI-based pain evaluation system using a green laser. An NMR titration analysis demonstrated that the compound strongly binds to the chemokine receptor-binding protein. BOLD-fMRI revealed that the allodynia-specific responses were suppressed by the administration of the compound, in a similar manner to the existing analgesic, pregabalin, with a completely different mechanism of action from that of the compound.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords